AirSculpt Technologies, Inc.
$2.64
▲
16.12%
2026-04-21 05:11:01
www.airsculpt.com
NGM: AIRS
Explore AirSculpt Technologies, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$180.6 M
Current Price
$2.64
52W High / Low
$12 / $1.51
Stock P/E
—
Book Value
$1.36
Dividend Yield
0%
ROCE
-0.99%
ROE
-14.06%
Face Value
—
EPS
$-0.19
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
330
Beta
2.27
Debt / Equity
95.28
Current Ratio
0.55
Quick Ratio
0.55
Forward P/E
-88
Price / Sales
1.23
Enterprise Value
$261.36 M
EV / EBITDA
32.88
EV / Revenue
1.72
Rating
Hold
Target Price
$6
EPS Forecast (FY)
—
Pros
- Core market and financial snapshot is available for screening.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | The Joint Corp. | $8.79 | 45.73 | $125.34 M | — | -3.22% | -1.5% | $13.47 / $7.5 | $1.06 |
| 2. | DaVita Inc. | $149.93 | 15.78 | $10.02 B | — | 14.02% | 64.85% | $159.42 / $101 | $-9.5 |
| 3. | Healthcare Services Group, Inc. | $19.32 | 22.48 | $1.33 B | — | 8.94% | 11.69% | $22.98 / $9.12 | $7.33 |
| 4. | InnovAge Holding Corp. | $7.95 | 172.72 | $1.12 B | — | -4.46% | 1.18% | $10.69 / $2.6 | $1.89 |
| 5. | Chemed Corporation | $385.77 | 19.4 | $5.15 B | 0.62% | 27.27% | 25.28% | $593.8 / $365.2 | $71.44 |
| 6. | COMPASS Pathways plc | $9.46 | — | $639.93 M | — | 468.11% | -5.65% | $8.9 / $2.25 | $-0.55 |
| 7. | U.S. Physical Therapy, Inc. | $75.72 | 28.66 | $431.66 M | 2.43% | 7.55% | 7.59% | $93.5 / $64.99 | $31.5 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 33.44 M | 34.99 M | 44.01 M | 39.37 M | 39.18 M | — |
| Operating Profit | -1.52 M | -2.61 M | 0.89 M | -1.59 M | -4.12 M | — |
| Net Profit | 1.28 M | -9.51 M | -0.59 M | -2.85 M | -5.03 M | — |
| EPS in Rs | 0.02 | -0.13 | -0.01 | -0.04 | -0.07 | -0.1 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 151.82 M | 180.35 M | 195.92 M | 168.79 M |
| Operating Profit | -4.83 M | -1.57 M | 9.51 M | -3.47 M |
| Net Profit | -11.67 M | -8.02 M | -4.24 M | -14.68 M |
| EPS in Rs | -0.17 | -0.11 | -0.06 | -0.21 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 187.3 M | 212.78 M | 204.02 M | 200.76 M |
| Total Liabilities | 99.59 M | 134.59 M | 120.03 M | 129.99 M |
| Equity | 87.71 M | 78.19 M | 83.99 M | 70.77 M |
| Current Assets | 15.46 M | 17.12 M | 15.96 M | 16.68 M |
| Current Liabilities | 27.9 M | 28.95 M | 20.32 M | 22.32 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 3.1 M | 11.35 M | 23.96 M | 24.45 M |
| Investing CF | -2.4 M | -14.01 M | -9.92 M | -12.92 M |
| Financing CF | -0.48 M | 0.63 M | -13.39 M | -27.26 M |
| Free CF | 0.69 M | -2.66 M | 14.04 M | 11.53 M |
| Capex | -2.4 M | -14.01 M | -9.92 M | -12.92 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -7.95% | 16.07% | — | — |
| Earnings Growth % | -89.1% | 71.12% | — | — |
| Profit Margin % | -4.45% | -2.16% | -8.7% | — |
| Operating Margin % | -0.87% | 4.85% | -2.05% | — |
| Gross Margin % | 60.55% | 62.34% | 62.81% | — |
| EBITDA Margin % | 5.71% | 10.2% | 2.08% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2022-08-25 | $0.41 |
Stock Splits
No stock split history available.